Skip to main content
. 2019 Jan 10;4(1):e124643. doi: 10.1172/jci.insight.124643

Figure 2. Ranolazine treatment does not influence insulin sensitivity.

Figure 2

(A and B) Insulin tolerance in lean and obese mice treated with either vehicle control (VC) or ranolazine (Ran) (n = 12–15). (C) Insulin signaling (Akt and GSK3β phosphorylation) in soleus from obese mice treated with either VC or Ran (n = 4). Values represent means ± SEM.